{"id":187,"date":"2019-12-12T14:20:39","date_gmt":"2019-12-12T14:20:39","guid":{"rendered":"https:\/\/www.cairnsurgical.com\/?page_id=187"},"modified":"2026-05-01T16:44:20","modified_gmt":"2026-05-01T16:44:20","slug":"news","status":"publish","type":"page","link":"https:\/\/www.cairnsurgical.com\/others\/news\/","title":{"rendered":"News"},"content":{"rendered":"

[et_pb_section fb_built=”1″ _builder_version=”3.22.4″][et_pb_row _builder_version=”3.22.4″][et_pb_column type=”1_2″ _builder_version=”3.22.4″][et_pb_text _builder_version=”3.22.4″]<\/p>\n

News<\/h1>\n

[\/et_pb_text][et_pb_blurb title=”CairnSurgical Reports Pivotal Trial Results for Its BCL System” url=”https:\/\/www.businesswire.com\/news\/home\/20260501542925\/en\/Cairn-Surgical-Reports-Pivotal-Trial-Results-for-Its-Breast-Cancer-Locator-System” url_new_window=”on” image=”https:\/\/www.cairnsurgical.com\/others\/wp-content\/uploads\/2023\/01\/abt2-1-1.png” _builder_version=”3.22.4″ animation=”off” link_option_url=”https:\/\/www.businesswire.com\/news\/home\/20260501542925\/en\/Cairn-Surgical-Reports-Pivotal-Trial-Results-for-Its-Breast-Cancer-Locator-System” link_option_url_new_window=”on”]<\/p>\n

LEBANON, N.H., May 1, 2026–(BUSINESS WIRE)–Cairn Surgical, Inc., an innovative medical technology company striving to make breast cancer surgery more precise, announced today the results of its pivotal trial evaluating its investigational Breast Cancer Locator (BCLTM) System. The study met its primary endpoint and reported a lower positive margin rate (PMR) across all cancer types when compared to conventional wire localization (WL). Results were presented at the annual meeting of the American Society of Breast Surgeons (ASBrS) currently underway in Seattle.<\/p>\n

[\/et_pb_blurb][et_pb_blurb title=”CairnSurgical Announces FDA De Novo 510(k) Submission for BCL System” url=”https:\/\/www.businesswire.com\/news\/home\/20260311288008\/en\/Cairn-Surgical-Announces-FDA-De-Novo-510k-Submission-for-Breast-Cancer-Locator-System” url_new_window=”on” image=”https:\/\/www.cairnsurgical.com\/others\/wp-content\/uploads\/2019\/12\/bright-crop-scaled.jpg” _builder_version=”3.22.4″ animation=”off” link_option_url=”https:\/\/www.businesswire.com\/news\/home\/20260311288008\/en\/Cairn-Surgical-Announces-FDA-De-Novo-510k-Submission-for-Breast-Cancer-Locator-System” link_option_url_new_window=”on”]<\/p>\n

LEBANON, N.H., March 11, 2026–(BusinessWire)–Cairn Surgical, Inc., an innovative medical technology firm striving to make breast cancer surgery more precise, announced today that it has submitted a De Novo 510(k) application to the U.S. Food and Drug Administration (FDA) seeking marketing clearance for its Breast Cancer Locator (BCLTM) System.<\/p>\n

[\/et_pb_blurb][et_pb_blurb title=”New Study Combining Prone and Supine MRI” url=”https:\/\/www.businesswire.com\/news\/home\/20260224512996\/en\/New-Study-Shows-Combining-Prone-and-Supine-MRI-in-Single-Session-Before-Breast-Conserving-Surgery-Provides-Highly-Accurate-Tumor-Imagery-Efficiently-and-Conveniently” url_new_window=”on” image=”https:\/\/www.cairnsurgical.com\/others\/wp-content\/uploads\/2023\/01\/abt2-1-1.png” _builder_version=”3.22.4″ animation=”off” link_option_url=”https:\/\/www.businesswire.com\/news\/home\/20260224512996\/en\/New-Study-Shows-Combining-Prone-and-Supine-MRI-in-Single-Session-Before-Breast-Conserving-Surgery-Provides-Highly-Accurate-Tumor-Imagery-Efficiently-and-Conveniently” link_option_url_new_window=”on”]<\/p>\n

LEBANON, N.H., February 24, 2026–(BusinessWire)–New Study Shows Combining Prone and Supine MRI in Single Session Before Breast Conserving Surgery Provides Highly Accurate Tumor Imagery, Efficiently and Conveniently.<\/p>\n

[\/et_pb_blurb][et_pb_blurb title=”MedTech Strategist – Breast Cancer Innovators” url=”https:\/\/www.cairnsurgical.com\/others\/wp-content\/uploads\/2026\/01\/MedTech-Strategist-January-2026-Breast-Cancer-Innovators-Are-coming-up-the-Curve.pdf” url_new_window=”on” image=”https:\/\/www.cairnsurgical.com\/others\/wp-content\/uploads\/2019\/12\/bright-crop-scaled.jpg” _builder_version=”3.22.4″ animation=”off” link_option_url=”https:\/\/www.cairnsurgical.com\/others\/wp-content\/uploads\/2026\/01\/MedTech-Strategist-January-2026-Breast-Cancer-Innovators-Are-coming-up-the-Curve.pdf” link_option_url_new_window=”on”]<\/p>\n

LEBANON, N.H., January 27, 2026–(MedTech Strategist)–Cairn Surgical, Inc., Guides Breast Cancer Surgeons to Cleaner Margins.<\/p>\n

[\/et_pb_blurb][et_pb_blurb title=”CairnSurgical Announces Completion of Enrollment in U.S. Pivotal Trial of Novel BCL System” url=”https:\/\/www.businesswire.com\/news\/home\/20260107085136\/en\/Cairn-Surgical-Announces-Completion-of-Enrollment-in-U.S.-Pivotal-Trial-of-Novel-Breast-Cancer-Locator-System” url_new_window=”on” image=”https:\/\/www.cairnsurgical.com\/others\/wp-content\/uploads\/2019\/12\/bright-crop-scaled.jpg” _builder_version=”3.22.4″ animation=”off” link_option_url=”https:\/\/www.businesswire.com\/news\/home\/20260107085136\/en\/Cairn-Surgical-Announces-Completion-of-Enrollment-in-U.S.-Pivotal-Trial-of-Novel-Breast-Cancer-Locator-System” link_option_url_new_window=”on”]<\/p>\n

LEBANON, N.H., January 7, 2026–(BUSINESS WIRE)–Cairn Surgical, Inc., an innovative medical technology firm striving to make breast cancer surgery more precise, announced today that patient enrollment has been completed in the U.S. pivotal trial of its Breast Cancer Locator (BCLTM) System.<\/p>\n

[\/et_pb_blurb][et_pb_blurb title=”New Published Data Shows BCL Dramatically Improves Surgeon Ability To Remove Entire Tumor With Negative Margins” url=”https:\/\/www.cairnsurgical.com\/others\/news-bcl-2025-10-21\/” url_new_window=”on” image=”https:\/\/www.cairnsurgical.com\/others\/wp-content\/uploads\/2023\/01\/abt2-1-1.png” _builder_version=”3.22.4″ animation=”off” link_option_url=”https:\/\/www.cairnsurgical.com\/others\/news-bcl-2025-10-21\/” link_option_url_new_window=”on”]<\/p>\n

LEBANON, N.H., October 21, 2025– CairnSurgical announced a multicenter study just published demonstrated that the BCL system met its primary endpoint, enabling breast surgeons to successfully remove the entire tumor with negative margins in 94% of patients.<\/p>\n

[\/et_pb_blurb][et_pb_blurb title=”CairnSurgical Achieves ISO 13485 Certification” url=”https:\/\/www.businesswire.com\/news\/home\/20250724902138\/en\/Cairn-Surgical-Achieves-ISO-13485-Certification” url_new_window=”on” image=”https:\/\/www.cairnsurgical.com\/others\/wp-content\/uploads\/2019\/12\/bright-crop-scaled.jpg” _builder_version=”3.22.4″ animation=”off” link_option_url=”https:\/\/www.businesswire.com\/news\/home\/20250724902138\/en\/Cairn-Surgical-Achieves-ISO-13485-Certification” link_option_url_new_window=”on”]<\/p>\n

LEBANON, N.H., July 24, 2025–(BUSINESS WIRE)–Cairn Surgical achieves ISO 13485 certification. [read more via Business Wire]<\/p>\n

[\/et_pb_blurb][et_pb_blurb title=”CairnSurgical announces first commercial use of novel Breast Cancer Locator System” url=”https:\/\/finance.yahoo.com\/news\/cairn-surgical-announces-first-commercial-120000420.html” url_new_window=”on” image=”https:\/\/www.cairnsurgical.com\/others\/wp-content\/uploads\/2019\/12\/bright-crop-scaled.jpg” _builder_version=”3.22.4″ animation=”off” link_option_url=”https:\/\/finance.yahoo.com\/news\/cairn-surgical-announces-first-commercial-120000420.html” link_option_url_new_window=”on”]<\/p>\n

LEBANON, N.H., September 19, 2024–(BUSINESS WIRE)–Cairn Surgical, Inc., an innovative medical technology firm striving to make breast cancer surgery more precise, announced today that the first commercial case using its Breast Cancer Locator (BCL\u2122) System has been performed by Prof. Dr. med. Hisham Fansa, head of the Breast Center and head of plastic surgery at Spital Zollikerberg, Z\u00fcrich, Switzerland. [read more via Yahoo Finance \/ Business Wire]<\/p>\n

[\/et_pb_blurb][et_pb_blurb title=”CairnSurgical completes enrollment in European study of novel Breast Cancer Locator system” url=”https:\/\/www.businesswire.com\/news\/home\/20240904617299\/en\/Cairn-Surgical-Completes-Enrollment-in-European-Study-of-Novel-Breast-Cancer-Locator-System” url_new_window=”on” image=”https:\/\/www.cairnsurgical.com\/others\/wp-content\/uploads\/2023\/01\/abt2-1-1.png” _builder_version=”3.22.4″ animation=”off” link_option_url=”https:\/\/www.businesswire.com\/news\/home\/20240904617299\/en\/Cairn-Surgical-Completes-Enrollment-in-European-Study-of-Novel-Breast-Cancer-Locator-System” link_option_url_new_window=”on”]<\/p>\n

CairnSurgical completed enrollment its European post-market clinical study<\/p>\n

[\/et_pb_blurb][et_pb_blurb title=”CairnSurgical closes $4.5 million in new financing for novel Breast Cancer Locator System designed to improve breast cancer surgery” url=”https:\/\/finance.yahoo.com\/news\/cairn-surgical-closes-4-5-120000684.html#” url_new_window=”on” image=”https:\/\/www.cairnsurgical.com\/others\/wp-content\/uploads\/2019\/12\/bright-crop-scaled.jpg” _builder_version=”3.22.4″ animation=”off” link_option_url=”https:\/\/finance.yahoo.com\/news\/cairn-surgical-closes-4-5-120000684.html#” link_option_url_new_window=”on”]<\/p>\n

Funds to Support Pivotal Trial Completion and Early Commercialization<\/p>\n

[\/et_pb_blurb][et_pb_blurb title=”NH Tech Alliance Names the Breast Cancer Locator as Product of the Year” url=”https:\/\/nhtechalliance.org\/2021-product-of-the-year-announced\/” url_new_window=”on” image=”https:\/\/www.cairnsurgical.com\/others\/wp-content\/uploads\/2019\/12\/unnamed.jpg” _builder_version=”3.22.4″ animation=”off” link_option_url=”https:\/\/nhtechalliance.org\/2021-product-of-the-year-announced\/” link_option_url_new_window=”on”]<\/p>\n

CairnSurgical wins NH Product of the Year.<\/p>\n

[\/et_pb_blurb][et_pb_blurb title=”MedTech Strategist highlights CairnSurgical” url=”https:\/\/www.cairnsurgical.com\/others\/wp-content\/uploads\/2021\/05\/CairnSurg-MTS-5-2021-UL.pdf” url_new_window=”on” image=”https:\/\/www.cairnsurgical.com\/others\/wp-content\/uploads\/2020\/01\/bcl-render-2.png” _builder_version=”3.22.4″ animation=”off” link_option_url=”https:\/\/www.cairnsurgical.com\/others\/wp-content\/uploads\/2021\/05\/CairnSurg-MTS-5-2021-UL.pdf” link_option_url_new_window=”on”]<\/p>\n

CairnSurgical: Patient-Specific, Real-Time Guidance for Breast Cancer Surgery<\/p>\n

[\/et_pb_blurb][et_pb_blurb title=”CairnSurgical Announces First Patient Treated in Pivotal Clinical Trial of Breast Cancer Locator System” url=”https:\/\/www.businesswire.com\/news\/home\/20210121005264\/en\/CairnSurgical-Announces-First-Patient-Treated-in-Pivotal-Clinical-Trial-of-Breast-Cancer-Locator-System” url_new_window=”on” image=”https:\/\/www.cairnsurgical.com\/others\/wp-content\/uploads\/2019\/12\/bright-crop-scaled.jpg” _builder_version=”3.22.4″ animation=”off” link_option_url=”https:\/\/www.businesswire.com\/news\/home\/20210121005264\/en\/CairnSurgical-Announces-First-Patient-Treated-in-Pivotal-Clinical-Trial-of-Breast-Cancer-Locator-System” link_option_url_new_window=”on”]<\/p>\n

The first patient has been treated in the pivotal clinical trial using the Breast Cancer Locator (BCL) for surgical guidance at Massachusetts General Hospital.<\/p>\n

[\/et_pb_blurb][et_pb_blurb title=”CairnSurgical Completes Series A investment” url=”https:\/\/celdaramedical.com\/blog\/181-cairnsurgical-inc-driven-hub-s-first-participant-company-announces-series-a-investment-led-by-morningside-group” url_new_window=”on” image=”https:\/\/www.cairnsurgical.com\/others\/wp-content\/uploads\/2019\/12\/unnamed.jpg” _builder_version=”3.22.4″ animation=”off” link_option_url=”https:\/\/celdaramedical.com\/blog\/181-cairnsurgical-inc-driven-hub-s-first-participant-company-announces-series-a-investment-led-by-morningside-group” link_option_url_new_window=”on”]<\/p>\n

Celdara Medical announced that the first DRIVEN Accelerator Hub Company, CairnSurgical, Inc., has closed a Series A investment led by Morningside Group. Click to read more.<\/p>\n

[\/et_pb_blurb][et_pb_blurb title=”CairnSurgical Announces First Patients Treated in Europe With Breast Cancer Locator System ” url=”https:\/\/www.businesswire.com\/news\/home\/20230124005343\/en\/CairnSurgical-Announces-First-Patients-Treated-in-Europe-With-Breast-Cancer-Locator-System?utm_campaign=shareaholic&utm_medium=copy_link&utm_source=bookmark” url_new_window=”on” image=”https:\/\/www.cairnsurgical.com\/others\/wp-content\/uploads\/2023\/01\/510-1.jpg” _builder_version=”3.22.4″ animation=”off” link_option_url=”https:\/\/www.businesswire.com\/news\/home\/20230124005343\/en\/CairnSurgical-Announces-First-Patients-Treated-in-Europe-With-Breast-Cancer-Locator-System?utm_campaign=shareaholic&utm_medium=copy_link&utm_source=bookmark” link_option_url_new_window=”on”]<\/p>\n

System Designed to Reduce the Incidence of Positive Margins \u2013 or Cancer Left Behind – After Breast Cancer Surgery<\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”3.22.4″][et_pb_text _builder_version=”3.22.4″]<\/p>\n

Publications<\/h1>\n

[\/et_pb_text][et_pb_text _builder_version=”3.22.4″]diFlorio-Alexander, R, Byrd, B, Krishnaswamy, V, Fox, M, Paulsen, K, Barth, R, Rooney, T. Prone-to-Supine Breast MRI for Tumor Margin Visibility and Surgical Guidance. Journal of Breast Imaging. 2026. doi:10.1093\/jbi\/wbaf059<\/a>.<\/p>\n

Barth, RJ Jr, Krishnaswamy, V, Rooney, TB, Fox, MJ, Burman, HEG, Rosenkranz, KM et al.. A pilot multi-institutional study to evaluate the accuracy of a supine MRI based guidance system, the Breast Cancer Locator\u2122, in patients with palpable breast cancer. Surg Oncol. 2022;44 :101843. doi: 10.1016\/j.suronc.2022.101843. PubMed PMID:36067629 .<\/p>\n

Byrd, BK, Krishnaswamy, V, Gui, J, Rooney, T, Zuurbier, R, Rosenkranz, K et al.. The shape of breast cancer. Breast Cancer Res Treat. 2020;183 (2):403-410. doi: 10.1007\/s10549-020-05780-6. PubMed PMID:32656723 PubMed Central PMC8256655.<\/p>\n

Barth, RJ Jr, Krishnaswamy, V, Paulsen, KD, Rooney, TB, Wells, WA, Angeles, CV et al.. A Randomized Prospective Trial of Supine MRI-Guided Versus Wire-Localized Lumpectomy for Breast Cancer. Ann Surg Oncol. 2019;26 (10):3099-3108. doi: 10.1245\/s10434-019-07531-4. PubMed PMID:31359283 .<\/p>\n

Barth, RJ Jr, Krishnaswamy, V, Paulsen, KD, Rooney, TB, Wells, WA, Rizzo, E et al.. A Patient-Specific 3D-Printed Form Accurately Transfers Supine MRI-Derived Tumor Localization Information to Guide Breast-Conserving Surgery. Ann Surg Oncol. 2017;24 (10):2950-2956. doi: 10.1245\/s10434-017-5979-z. PubMed PMID:28766199 PubMed Central PMC6015768.<\/p>\n

Thill, M, Ghilli, M, Roncella, M, Kelling, K, Fansa, H, Golatta, M, Heil, J et al. A Multi-Institutional Study to Evaluate the Effectiveness and Safety of a Supine MRI-Based Guidance System, the Breast Cancer Locator\u2122, for Breast Conserving Surgery in Patients with Nonpalpable Breast Cancer. Ann Surg Oncol. 2025;32:8636-8643. doi: 10.1245\/s10434-025-17513-4.[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”3.22.4″][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

[et_pb_section fb_built=”1″ _builder_version=”3.22.4″][et_pb_row _builder_version=”3.22.4″][et_pb_column type=”1_2″ _builder_version=”3.22.4″][et_pb_text _builder_version=”3.22.4″] News [\/et_pb_text][et_pb_blurb title=”CairnSurgical Reports Pivotal Trial Results for Its BCL System” url=”https:\/\/www.businesswire.com\/news\/home\/20260501542925\/en\/Cairn-Surgical-Reports-Pivotal-Trial-Results-for-Its-Breast-Cancer-Locator-System” url_new_window=”on” image=”https:\/\/www.cairnsurgical.com\/others\/wp-content\/uploads\/2023\/01\/abt2-1-1.png” _builder_version=”3.22.4″ animation=”off” link_option_url=”https:\/\/www.businesswire.com\/news\/home\/20260501542925\/en\/Cairn-Surgical-Reports-Pivotal-Trial-Results-for-Its-Breast-Cancer-Locator-System” link_option_url_new_window=”on”] LEBANON, N.H., May 1, 2026–(BUSINESS WIRE)–Cairn Surgical, Inc., an innovative medical technology company striving to make breast cancer surgery more precise, announced today the results of its pivotal trial evaluating […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":""},"_links":{"self":[{"href":"https:\/\/www.cairnsurgical.com\/others\/wp-json\/wp\/v2\/pages\/187"}],"collection":[{"href":"https:\/\/www.cairnsurgical.com\/others\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.cairnsurgical.com\/others\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.cairnsurgical.com\/others\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cairnsurgical.com\/others\/wp-json\/wp\/v2\/comments?post=187"}],"version-history":[{"count":31,"href":"https:\/\/www.cairnsurgical.com\/others\/wp-json\/wp\/v2\/pages\/187\/revisions"}],"predecessor-version":[{"id":855,"href":"https:\/\/www.cairnsurgical.com\/others\/wp-json\/wp\/v2\/pages\/187\/revisions\/855"}],"wp:attachment":[{"href":"https:\/\/www.cairnsurgical.com\/others\/wp-json\/wp\/v2\/media?parent=187"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}